In India, PCOD and PCOS are used interchangeably — but doctors know there's a difference, and it's worth understanding. Walk into a clinic, mention irregular periods and cysts on your ovaries, and you'll probably hear either diagnosis. But here's what's actually happening: one is a structural condition, and one is a systemic endocrine disorder. The distinction matters less than you'd think — what matters is your metabolic profile. Yet, many women are left confused, thinking the label defines their condition, when really it's the bloodwork that tells the story.
PCOD and PCOS are often confused but differ in severity. PCOD (Polycystic Ovarian Disease) involves enlarged ovaries with immature eggs—manageable with lifestyle changes. PCOS (Polycystic Ovarian Syndrome) is a metabolic-endocrine disorder with insulin resistance, hyperandrogenism, and long-term health risks. Both require biomarker testing to distinguish and properly treat.
| Feature | PCOD | PCOS |
|---|---|---|
| Definition | Structural: ovaries with cysts | Endocrine disorder: metabolic dysfunction |
| Cause | Immature eggs; primary cyst formation | Insulin resistance + hyperandrogenism |
| Severity | Mild; often asymptomatic | Moderate-severe; systemic impacts |
| Fertility Impact | Minimal if ovulating | Anovulation common; impacts fertility |
| Insulin Resistance | Not present | 70% prevalence; central to pathology |
| Treatment | Lifestyle changes often sufficient | Medication + lifestyle (metformin, inositol, spironolactone) |
| Monitoring | Annual bloodwork if asymptomatic | Quarterly tests; active protocol management |
Research Citations
Rotterdam Criteria (2003): Diagnosis requires 2 of 3: ovulatory dysfunction, hyperandrogenism, polycystic ovaries. Standard for PCOS. PubMed
Ultrasound Prevalence: Michelmore et al. (1999) showed 25% of normal women have polycystic-appearing ovaries; ultrasound alone is insufficient. PubMed
PCOS Prevalence in India: Jehan et al. (2021) estimated 20-30% of Indian women meet PCOS criteria; PCOD diagnosis is often misused colloquially. PubMed
Key Takeaways
In medical literature, the distinction is subtle but real. Let's define it properly.
PCOD stands for Polycystic Ovarian Disease. The definition is straightforward: your ovaries produce multiple immature eggs (follicles) that don't fully mature or release. Instead, they accumulate on the ovary as fluid-filled sacs, or "cysts." This is the structural finding on ultrasound.
The critical point: structural PCOD doesn't necessarily mean systemic dysfunction. You could have polycystic ovaries and still ovulate regularly, have normal hormone levels, and menstruate every 28-30 days. In that case, you have the appearance of PCOD but not the disease burden. Studies show that 20-25% of women without any reproductive symptoms have ultrasound findings consistent with PCOD. They don't need treatment; their ovaries just look that way.
PCOD symptoms (if present): Irregular or absent periods, difficulty conceiving, mild androgen excess (acne, excess hair growth), weight gain tendency.
PCOS stands for Polycystic Ovary Syndrome. The name is similar, the condition is categorically different. PCOS is not just polycystic ovaries; it's a metabolic and endocrine disorder characterized by:
PCOS is a true syndrome — a constellation of symptoms linked by underlying metabolic dysfunction. It's systemic, not just ovarian.
Since the late 1990s, doctors have used the Rotterdam criteria to diagnose PCOS. It requires 2 of 3 findings:
Here's the problem: this definition makes PCOD and PCOS essentially the same thing in clinical practice. A woman with polycystic ovaries + irregular periods automatically meets criteria for PCOS, even if her androgens are completely normal. A woman with elevated androgens + regular periods but normal-looking ovaries also has PCOS by Rotterdam criteria, even though she has no polycystic appearance.
The distinction in India: Indian physicians traditionally used "PCOD" to describe the structural finding alone (cysts visible on ultrasound). "PCOS" was reserved for the full syndrome with metabolic dysfunction. But in rigorous medical literature, both terms now describe the same Rotterdam-defined condition. The real question isn't PCOD vs PCOS — it's whether the condition carries metabolic complications that require treatment.
This is critical: you cannot diagnose PCOD or PCOS from ultrasound alone. Yet many women hear "you have cysts" and assume they have a disease.
The evidence is clear. Studies show:
A diagnosis of PCOD or PCOS requires more than ultrasound. It requires bloodwork to clarify what's actually happening metabolically.
Here are the tests that determine whether your PCOD/PCOS carries real disease burden and what treatment you need:
Elevated androgens define hyperandrogenism. Free testosterone (not total) is more specific; it reflects bioavailable hormones. If your free testosterone is elevated, that's metabolic dysfunction requiring treatment. If it's normal, you may have structural PCOD but not hormonal PCOS.
Another androgen marker. Elevated DHEA-S suggests adrenal androgen excess, a different metabolic phenotype than ovarian androgen excess. Some women have adrenal PCOS (elevated DHEA-S) without ovarian manifestations.
Insulin resistance is central to PCOS pathophysiology. Fasting insulin > 12 mIU/L or HOMA-IR > 2.0 indicates impaired glucose metabolism. This is where most Indian women with PCOS live — insulin resistance, even if they're lean.
Why this matters: Insulin-resistant PCOS requires metformin, inositol, or GLP-1 therapy. Insulin-sensitive PCOS may respond to anti-androgen medications like spironolactone or even lifestyle alone. The metabolic phenotype determines the treatment.
In PCOS, LH (luteinizing hormone) is often elevated relative to FSH, disrupting the follicle selection process and causing anovulation. An elevated LH:FSH ratio (>2:1 or 3:1) supports PCOS diagnosis but isn't required — some women have PCOS with normal ratios.
AMH reflects ovarian reserve and granulosa cell function. Elevated AMH is common in PCOS and associated with increased ovarian androgen production. AMH > 4.0 ng/mL suggests higher ovarian reserve and confirms PCOS phenotype, but it's not diagnostic alone.
Thyroid disease mimics PCOS: irregular periods, weight gain, fatigue. Rule it out. Many Indian women are hypothyroid, compounding metabolic dysfunction.
Elevated prolactin causes irregular periods and galactorrhea, mimicking PCOS. A simple prolactin test rules this out.
Many women with PCOS have impaired fasting glucose (100-125 mg/dL) or impaired glucose tolerance. Early detection of prediabetes is crucial for prevention.
Here's what matters: arq. doesn't prescribe based on diagnosis. We prescribe based on metabolic phenotype.
You might have:
The label matters less than the bloodwork. A woman with "PCOD" and severe insulin resistance needs as much treatment as a woman with "PCOS." Conversely, a woman with polycystic ovaries, regular periods, and normal metabolic markers may need no treatment at all.
Insulin-Resistant PCOS/PCOD:
Androgen-Excess PCOS/PCOD:
Lifestyle-First PCOD (benign phenotype):
arq. approaches each case individually. Your protocol is built from your bloodwork, not a template.
Unsure if you have PCOD, PCOS, or neither? The distinction is in your bloodwork. Talk to an arq. physician for metabolic assessment →
This is a common question from women diagnosed with PCOD in their 20s who wonder if it will "worsen" to PCOS.
The honest answer: not really, but also yes, semantically. Here's why:
If you have structural PCOD now (polycystic ovaries, regular periods, normal hormones), your ovarian appearance won't change. But if metabolic dysfunction develops — insulin resistance from weight gain, androgen excess from aging or other causes, anovulation — then the diagnosis shifts from "benign PCOD" to "metabolic PCOS." It's not the PCOD becoming PCOS; it's the unmasking of metabolic dysfunction that was always present or newly acquired.
The risk factors for progression: sedentary lifestyle, high-glycemic diet, weight gain, age (PCOS manifests more severely in 30s-40s), and genetic predisposition. Regular metabolic monitoring catches early dysfunction before it compounds.
Here's where PCOD vs PCOS becomes practically critical: fertility.
If you have PCOD with regular ovulation: Fertility is unaffected. Your ovaries release eggs normally. Conception is possible without intervention.
If you have PCOS with anovulation: You don't ovulate consistently. Conception is difficult or impossible without treatment.
The solution is testable and often treatable:
Many women with PCOS conceive naturally after metabolic treatment. The diagnosis is not infertility.
We've covered the key points above in our FAQ. These questions address the most common concerns and misunderstandings.
No AI chat. No templates. A specialist reads your panel against South Asian-calibrated ranges and writes the protocol on a 15–20 minute video consult — inside 7 days of your home draw.